TearCare in Young Adults

This study is a non-randomized, open-label, interventional trial of TearCare® eyelid warming and manual meibomian gland expression in young adults with clinically significant meibomian gland dysfunction (MGD). Intervention is with TearCare® performed at Visit 1. A single follow-up examination occurs at Day 28.

NCT Number	NCT07579156
Lead Sponsor	University of Alabama at Birmingham Collaborators: Sight Sciences, Inc.
Conditions	Meibomian Gland Dysfunction (Disorder)
Enrollment	45 participants
Start Date	2026-08-01
Primary Completion	2027-08-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-11